1) ABNORMALITY OF TYPE I INTERFERON SIGNALLING IN B CELLS IN PRIMARY SJOGREN'S SYNDROME AND THE IMPACT ON LABORATORY AND CLINICAL FINDINGS

被引：0
|
作者：
Ritter, J. [1 ]
Szelinski, F. [1 ]
Aue, A. [2 ]
Stefanski, A. [1 ]
Schrezenmeier, E. [2 ]
Lino, A. [3 ]
Doerner, T. [1 ]
机构：
[1] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany
[2] Charite Univ Med Berlin, Dept Nephrol & Intens Care, Berlin, Germany
[3] German Rheumatism Res Ctr DRFZ, Leibniz Inst, Berlin, Germany
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2022年 / 40卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
60
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [1] ABNORMALITY OF TYPE I INTERFERON SIGNALLING IN B CELLS IN PRIMARY SJOGREN'S SYNDROME AND THE IMPACT ON LABORATORY AND CLINICAL FINDINGS
    Ritter, J.
    Szelinski, F.
    Aue, A.
    Stefanski, A. L.
    Schrezenmeier, E.
    Doerner, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 480 - 480
  • [2] Primary Sjogren's Syndrome and the Type I Interferon System
    Nordmark, Gunnel
    Eloranta, Maija-Leena
    Ronnblom, Lars
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2012, 13 (10) : 2054 - 2062
  • [3] Clinical and laboratory findings of 148 patients with primary Sjogren's Syndrome
    Turk, T
    Keser, G
    Aksu, K
    Kabasakal, Y
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 463 - 463
  • [4] Activation of the type I interferon pathway in primary Sjogren's syndrome
    Mavragani, Clio P.
    Crow, Mary K.
    JOURNAL OF AUTOIMMUNITY, 2010, 35 (03) : 225 - 231
  • [5] Primary Sjogren's syndrome and high type I interferon signalling in a kindred with C2 deficiency
    Willemsen, Mathijs
    Van Nieuwenhove, Erika
    Seyed Tabib, Nasim Sadat
    Staels, Frederik
    Schrijvers, Rik
    De Somer, Lien
    Liston, Adrian
    Humblet-Baron, Stephanie
    Wouters, Carine
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2022, 6 (01)
  • [6] Mechanisms of disease:: primary Sjogren's syndrome and the type I interferon system
    Nordmark, G
    Alm, GV
    Rönnblom, L
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (05): : 262 - 269
  • [7] Activation of the type I interferon pathway in primary Sjogren's syndrome: an update
    Vakaloglou, Katerina M.
    Mavragani, Clio P.
    CURRENT OPINION IN RHEUMATOLOGY, 2011, 23 (05) : 459 - 464
  • [8] Type I interferon signature in Sjogren's syndrome: pathophysiological and clinical implications
    Marketos, N.
    Cinoku, I.
    Rapti, A.
    Mavragani, C. P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (03) : S185 - S191
  • [9] Clinical and laboratory findings of primary Sjogren's syndrome patients without sicca symptoms
    Chatzis, L. G.
    Koulouri, V.
    Baldini, C.
    Pezoulas, V. C.
    Voulgari, P. V.
    Skopouli, F. N.
    Fotiadis, D. I.
    Tzioufas, A. G.
    Goules, A. V.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (12) : 2298 - 2302
  • [10] Type I Interferon Signature in Primary Antiphospholipid Syndrome: Clinical and Laboratory Associations
    Palli, Eleni
    Kravvariti, Evrydiki
    Tektonidou, Maria G.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
12345